Acute Respiratory Distress Syndrome Clinical Trial
— ARISE-AFRICAOfficial title:
A Multicentre, Randomized, Clinical Trial of Respiratory Support With Standard Low Flow Oxygen Therapy, Continuous Positive Airway Pressure, and High-flow Oxygen Therapy in Adults With Acute Hypoxemic Respiratory Failure in Uganda
The dearth of Intensive care units in low resource settings portends for poor outcomes amongst patients with acute hypoxemic respiratory failure (AHRF) . To our knowledge, the effect of CPAP and HFNC on major outcomes has not been assessed in adults with AHRF in resource-limited settings. The aim of this prospective, multicenter, randomized, controlled, trial is to determine whether High-flow oxygen through a nasal cannula (HFNC) or Continuous positive airway pressure (CPAP) system can reduce mortality among patients with acute hypoxemic respiratory failure (AHRF) in a limited resource setting as compared with standard low flow oxygen therapy?
Status | Recruiting |
Enrollment | 504 |
Est. completion date | January 16, 2024 |
Est. primary completion date | December 15, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 95 Years |
Eligibility | Inclusion Criteria: - De novo acute respiratory distress, as defined by dyspnea, use of accessory respiratory muscles, and a respiratory rate of 25 breaths per minute or more, - Hypoxemia, as defined by a ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FiO2) of less than 300 mm Hg or a oxygen saturation by pulse oximetry SpO2/FiO2 ratio <315 will be considered for inclusion - Informed consent obtained in accordance with local regulations; Exclusion Criteria: - Exacerbation of asthma, chronic obstructive pulmonary disease or another known or suspected chronic respiratory disease; - Absolute contraindications to CPAP or HFNC - Cardiac arrest; severe ventricular arrhythmia; shock defined by the need for vasopressors (dopamine > 5 microg/kg/min or adrenaline or noradrenaline at any dose) - Altered consciousness (Coma Glasgow Score below 12 points); - Do not intubate order, do not resuscitate order, or decision to limit full care taken before obtaining informed consent; - Refusal to participate, prior enrolment in the trial, participation in another interventional study on respiratory distress; |
Country | Name | City | State |
---|---|---|---|
Uganda | Entebbe Regional Referral Hospital | Entebbe | |
Uganda | St Mary's, Lacor | Gulu | |
Uganda | Hoima Regional referral Hospital | Hoima | |
Uganda | Jinja Regional Referral Hospital | Jinja | |
Uganda | Kabale Regional Referral Hospital | Kabale | |
Uganda | Kampala hospital | Kampala | |
Uganda | Kiruddu National referral Hospital | Kampala | |
Uganda | Mulago National Specialised Hospital | Kampala | |
Uganda | Naguru Referral Hospital | Kampala | |
Uganda | Nsambya Hospital | Kampala | |
Uganda | Rubaga Hospital | Kampala | |
Uganda | TMR International Hospital | Kampala | |
Uganda | Kisoro District Hospital | Kisoro | |
Uganda | Masaka regional Referral Hospital | Masaka | |
Uganda | Mbale Regional referral Hospital | Mbale | |
Uganda | Mbarara Regional referral Hospital | Mbarara | |
Uganda | Mengo Hospital | Mengo |
Lead Sponsor | Collaborator |
---|---|
Makerere University | Paris 12 Val de Marne University, THRiVE, Wellcome Trust |
Uganda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality | Number of study participants deceased at day 28 of study randomisation | 28 day | |
Secondary | Number of patients intubated and ventilator-free | Number of patients intubated and ventilator-free at 28 days from randomisation | 28 days | |
Secondary | Patient Tolerance to CPAP or HFNC | Patients will be assessed using the Likert scale | 7 days | |
Secondary | Organ failure free days | Number of days from randomisation free of organ failure | 7 days | |
Secondary | Number of patients who meet criteria for intubation at day 7 | Number of patients who meet criteria for intubation at day 7 of randomisation | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A |